Injective vs Morpho — how do they compare? Injective trades at Rp92,221 (market cap Rp9,27T, Rp1,77T 24h volume), while Morpho trades at Rp36,895 (market cap Rp19,17T, Rp341,18M 24h volume). The key difference: Morpho is far larger — about 2.1× Injective's market cap, and Morpho's supply is capped (516,3M / 1B MORPHO (52%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Morpho for 15 Days on average.
| INJ | MORPHO | |
|---|---|---|
Market Cap | Rp9,27T | Rp19,17T |
Volume (24h) | Rp1,77T | Rp341,18M |
Circulating Supply | 100M INJ | 516,3M / 1B MORPHO (52%) |
Typical Hold Time | 36 Days | 15 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp90,066 with a market cap of Rp8.94 trillion, exhibiting a bullish technical signal supported by moving averages while oscillators remain neutral. The current price sits above key support levels, with resistance near Rp93,589. Recent on-chain data indicates an average hold time of 36 days, suggesting moderate holder confidence. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.
Overall outlook is cautiously optimistic due to bullish technicals, but key risks include high volatility and neutral oscillators signaling potential overbought conditions. Opportunities lie in continued network adoption, while investors should monitor regulatory developments and liquidity depth closely. Major risks involve crypto market volatility and lack of recent fundamental catalysts.
Morpho is trading at Rp37,327 with a market cap of Rp19.17T, showing a bullish technical signal supported by moving averages while oscillators remain neutral. The asset is in an uptrend with key resistance at Rp38,740 and support at Rp35,927. No recent protocol updates or major ecosystem news are noted, but the token maintains a 52% circulation rate with a 15-day average hold time.
Overall outlook is cautiously optimistic due to bullish technicals, but limited fundamental developments and neutral sentiment pose risks. Key opportunities include breaking resistance for further gains, while major risks involve low liquidity and crypto market volatility. Investors should monitor for new ecosystem activity.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Morpho is an open, efficient, and trustless platform designed for earning yield and borrowing assets. Lenders utilize Morpho Vaults to maximize their returns, while borrowers gain access to assets through Morpho Markets. Its permissionless infrastructure empowers developers and businesses to create markets, curate vaults, and build applications. With immutable contracts, isolated lending markets, improved interest rates, and low gas fees, Morpho offers efficiency, flexibility, and a developer-friendly environment.
Read more on MORPHO →